Allotex - Tissue Addition Symposium
Barcelona 2024
CEO David Muller
Allotex - Tissue Addition Symposium
Barcelona 2024
Dr Aylin Kilic - Istanbul, Turkey
Allotex - Tissue Addition Symposium
Barcelona 2024
Mr Brendan Cummings - Dublin, Ireland
Allotex - Tissue Addition Symposium
Barcelona 2024
Dr Francesco Carones - Milan, Italy
Allotex
Downloadable PDF's
Excimer Laser Shaped Allograft Corneal Inlays for Presbyopia:
Initial Clinical Results of a Pilot Study
New Inlay Combines
Vintage
Theories and Contemporary Capabilities
The Genesis of Allogenic Inlays
Are allogenic corneal inlays becoming a feasible option for refractive correction?
Allotex
Articles
Allotex and 3D-Micromac develop biocompatible corneal inlays
Jan 2017
New Inlay Combines Vintage Theories and Contemporary Capabilities
May 2016
Future refractive technologies: thoughts and early experiences
September 2018
Biological corneal inlay for presbyopia derived from small incision lenticule extraction (SMILE)
January 2018
Allotex
Press Releases
Allotex, Inc. Announces Financing for Presbyopia Clinical Trials
Boston, MA, Feb 28, 2018
First Patient Treated in Multicenter Trial Examining Allotex TransForm Allogenic Refractive Lenticules for Treatment of Presbyopia
Boston, MA, Sep 13, 2018
Allotex Announces New Investor and Expansion of Production Facilities
Boston, MA – Milan, Italy – November 30, 2023